MedTrace Logo

Artemisinin Resistance in Cambodia

NCT00479206 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2008-04-30

No results posted yet for this study

Summary

The principal aim of this project is to investigate reports of developing artemisinin resistance in Cambodia using an integrated in vivo - in vitro approach to examine recent alarming reports of treatment failures with advanced combination therapies along the Thai-Cambodian border, which could have major impact on the malaria situation in the affected areas as well as the rest of the malaria-endemic world.

Conditions

  • Malaria, Falciparum

Interventions

DRUG

Artesunate

Sponsors & Collaborators

  • Global Emerging Infections Surveillance and Response System

    collaborator FED

  • Armed Forces Research Institute of Medical Sciences, Thailand

    collaborator OTHER_GOV

  • National Center for Parasitology, Entomology and Malaria Control

    collaborator UNKNOWN

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Harald Noedl, MD, MCTM, PhD · USAMC-AFRIMS

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-10-31
Completion
2007-02-28

Countries

  • Cambodia

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00479206 on ClinicalTrials.gov